Ann: Full Year Results Presentation, page-41

First 41 Last

Share
Profile

Follow
Wing it

288 Posts.

8

22/12/18

17:00

Post #: 36944951
Share

Originally posted by avtek ↑

from the spheria august investment update....

"The reaction to the new affiliation agreement was startling as we believe the new terms to be quite favourable for shareholders, particularly given the cricket rights could lead to a significant upward shift in revenue share, particularly in the regional markets where pay-TV is less penetrated. Furthermore, there are signs of stabilisation in the regional TV markets that tend to lag the metro markets which have returned to growth.

In fact, we forecast PRT to generate EBITDA in the $35 to $40m range in FY19, only slightly down on the $45m in FY18. We believe EBITDA is a better proxy of profit/cash flow given capex for the business is $3-4m a year whereas depreciation will be >$12m due to legacy amortisation and depreciations costs which
artificially deflate NPAT (including NPAT guidance provided by company). In fact, we calculate the
company is trading on 2.4x pre-tax free cash flow, which means shareholders will get their money back
in 2.4 years – all other thing being equal.

Add to that they have nearly $60m of franking credits versus a market cap of $87m and you quickly realise this company is brimming with value. In addition to its stand-alone valuation, there are enormous synergies in SWM buying PRT such that a merger is undeniably a huge win-win for both sets of shareholders. We estimate the synergies for SWM at >$10m p.a. assuming elimination of head office costs and national sales force duplication. This is one of the key reasons for our large exposure in SWM."

Expand

Still early days but it looks as though Spheria will be fairly close to the mark.

Federal and State elections next year should give an additional boost in the second half.

Last edited by Wing it: 22/12/18

PRT Price at posting: 20.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

There are more pages in this discussion • 2 more messages in this thread...

First 41 Last

Add PRT (ASX) to my watchlist

Ann: Full Year Results Presentation, page-41

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks